A Study of MELT-300 (Midazolam and Ketamine Sublingual Tablets) for Sedation and Intraoperative Ocular Analgesia in Participants Undergoing Cataract Extraction With Lens Replacement (CELR)

NCT05133518 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

338

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract

Interventions

DRUG: MELT-300
DRUG: Midazolam alone
DRUG: Ketamine alone
DRUG: Placebo

Sponsor

Melt Pharmaceuticals

Collaborators

[object Object]